Literature DB >> 15791206

Role that phosphorylation of GSK3 plays in insulin and Wnt signalling defined by knockin analysis.

Edward J McManus1, Kei Sakamoto, Laura J Armit, Leah Ronaldson, Natalia Shpiro, Rodolfo Marquez, Dario R Alessi.   

Abstract

The inactivation of glycogen synthase kinase (GSK)3 has been proposed to play important roles in insulin and Wnt signalling. To define the role that inactivation of GSK3 plays, we generated homozygous knockin mice in which the protein kinase B phosphorylation sites on GSK3alpha (Ser21) and GSK3beta (Ser9) were changed to Ala. The knockin mice were viable and were not diabetic. Using these mice we show that inactivation of GSK3beta rather than GSK3alpha is the major route by which insulin activates muscle glycogen synthase. In contrast, we demonstrate that the activation of muscle glycogen synthase by contraction, the stimulation of muscle glucose uptake by insulin, or the activation of hepatic glycogen synthase by glucose do not require GSK3 phosphorylation on Ser21/Ser9. GSK3 also becomes inhibited in the Wnt-signalling pathway, by a poorly defined mechanism. In GSK3alpha/GSK3beta homozygous knockin cells, Wnt3a induces normal inactivation of GSK3, as judged by the stabilisation of beta-catenin and stimulation of Wnt-dependent transcription. These results establish the function of Ser21/Ser9 phosphorylation in several processes in which GSK3 inactivation has previously been implicated.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15791206      PMCID: PMC1142569          DOI: 10.1038/sj.emboj.7600633

Source DB:  PubMed          Journal:  EMBO J        ISSN: 0261-4189            Impact factor:   11.598


  38 in total

1.  The muscle-specific protein phosphatase PP1G/R(GL)(G(M))is essential for activation of glycogen synthase by exercise.

Authors:  W G Aschenbach; Y Suzuki; K Breeden; C Prats; M F Hirshman; S D Dufresne; K Sakamoto; P G Vilardo; M Steele; J H Kim; S L Jing; L J Goodyear; A A DePaoli-Roach
Journal:  J Biol Chem       Date:  2001-08-24       Impact factor: 5.157

2.  Glycogen synthase kinase 3 phosphorylates kinesin light chains and negatively regulates kinesin-based motility.

Authors:  Gerardo Morfini; Györgyi Szebenyi; Ravindhra Elluru; Nancy Ratner; Scott T Brady
Journal:  EMBO J       Date:  2002-02-01       Impact factor: 11.598

3.  Akt participation in the Wnt signaling pathway through Dishevelled.

Authors:  S Fukumoto; C M Hsieh; K Maemura; M D Layne; S F Yet; K H Lee; T Matsui; A Rosenzweig; W G Taylor; J S Rubin; M A Perrella; M E Lee
Journal:  J Biol Chem       Date:  2001-03-09       Impact factor: 5.157

Review 4.  Convergence of Wnt, beta-catenin, and cadherin pathways.

Authors:  W James Nelson; Roel Nusse
Journal:  Science       Date:  2004-03-05       Impact factor: 47.728

5.  Contraction regulation of Akt in rat skeletal muscle.

Authors:  Kei Sakamoto; Michael F Hirshman; William G Aschenbach; Laurie J Goodyear
Journal:  J Biol Chem       Date:  2002-01-23       Impact factor: 5.157

6.  Exercise modulates postreceptor insulin signaling and glucose transport in muscle-specific insulin receptor knockout mice.

Authors:  J F Wojtaszewski; Y Higaki; M F Hirshman; M D Michael; S D Dufresne; C R Kahn; L J Goodyear
Journal:  J Clin Invest       Date:  1999-11       Impact factor: 14.808

Review 7.  GSK3 takes centre stage more than 20 years after its discovery.

Authors:  S Frame; P Cohen
Journal:  Biochem J       Date:  2001-10-01       Impact factor: 3.857

8.  A role for kinesin in insulin-stimulated GLUT4 glucose transporter translocation in 3T3-L1 adipocytes.

Authors:  M Emoto; S E Langille; M P Czech
Journal:  J Biol Chem       Date:  2001-01-05       Impact factor: 5.157

9.  Differential regulation of glycogen synthase kinase 3beta by insulin and Wnt signaling.

Authors:  V W Ding; R H Chen; F McCormick
Journal:  J Biol Chem       Date:  2000-10-20       Impact factor: 5.157

10.  Selective small molecule inhibitors of glycogen synthase kinase-3 modulate glycogen metabolism and gene transcription.

Authors:  M P Coghlan; A A Culbert; D A Cross; S L Corcoran; J W Yates; N J Pearce; O L Rausch; G J Murphy; P S Carter; L Roxbee Cox; D Mills; M J Brown; D Haigh; R W Ward; D G Smith; K J Murray; A D Reith; J C Holder
Journal:  Chem Biol       Date:  2000-10
View more
  283 in total

1.  Inhibition of glycogen synthase kinase 3[beta] activity with lithium in vitro attenuates sepsis-induced changes in muscle protein turnover.

Authors:  Stephen Bertsch; Charles H Lang; Thomas C Vary
Journal:  Shock       Date:  2011-03       Impact factor: 3.454

Review 2.  Wnt/beta-catenin signaling in glioma.

Authors:  Kailiang Zhang; Junxia Zhang; Lei Han; Peiyu Pu; Chunsheng Kang
Journal:  J Neuroimmune Pharmacol       Date:  2012-03-28       Impact factor: 4.147

Review 3.  When pathways collide: collaboration and connivance among signalling proteins in development.

Authors:  Helen McNeill; James R Woodgett
Journal:  Nat Rev Mol Cell Biol       Date:  2010-05-12       Impact factor: 94.444

4.  CCN5: biology and pathophysiology.

Authors:  Joshua W Russo; John J Castellot
Journal:  J Cell Commun Signal       Date:  2010-09-21       Impact factor: 5.782

5.  Glycogen synthase kinase-3 is an early determinant in the differentiation of pathogenic Th17 cells.

Authors:  Eléonore Beurel; Wen-I Yeh; Suzanne M Michalek; Laurie E Harrington; Richard S Jope
Journal:  J Immunol       Date:  2010-12-29       Impact factor: 5.422

Review 6.  Presenilin: RIP and beyond.

Authors:  Matthew R Hass; Chihiro Sato; Raphael Kopan; Guojun Zhao
Journal:  Semin Cell Dev Biol       Date:  2008-11-27       Impact factor: 7.727

7.  Akt2 influences glycogen synthase activity in human skeletal muscle through regulation of NH₂-terminal (sites 2 + 2a) phosphorylation.

Authors:  Martin Friedrichsen; Jesper B Birk; Erik A Richter; Rasmus Ribel-Madsen; Christian Pehmøller; Bo Falck Hansen; Henning Beck-Nielsen; Michael F Hirshman; Laurie J Goodyear; Allan Vaag; Pernille Poulsen; Jørgen F P Wojtaszewski
Journal:  Am J Physiol Endocrinol Metab       Date:  2013-01-15       Impact factor: 4.310

8.  Examination of methylphenidate-mediated behavior regulation by glycogen synthase kinase-3 in mice.

Authors:  Marjelo A Mines; Eleonore Beurel; Richard S Jope
Journal:  Eur J Pharmacol       Date:  2012-10-23       Impact factor: 4.432

Review 9.  AKT/PKB Signaling: Navigating the Network.

Authors:  Brendan D Manning; Alex Toker
Journal:  Cell       Date:  2017-04-20       Impact factor: 41.582

Review 10.  Regulation of inflammation and T cells by glycogen synthase kinase-3: links to mood disorders.

Authors:  Eleonore Beurel
Journal:  Neuroimmunomodulation       Date:  2014-02-14       Impact factor: 2.492

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.